Abstract
Freedom to merge: A combination of crystal structure examination and in silico predictions made it possible to overcome the conformational limitations of fragment merging and escape the internal strain in a series of weakly binding merged fragments that target M. tuberculosis CYP121. The insights attained provide a new perspective and guide for prioritizing synthetic efforts toward fragment merging in future and ongoing fragment‐based ligand discovery campaigns.
Original language | English |
---|---|
Pages (from-to) | 1451-1456 |
Number of pages | 6 |
Journal | ChemMedChem |
Volume | 8 |
Issue number | 9 |
Early online date | 20 Jun 2013 |
DOIs | |
Publication status | Published - 1 Sep 2013 |
Externally published | Yes |